The effects of obsessive compulsive disorder (OCD) create an economic burden to the U.K. totaling a staggering £5 billion, a new study titled "A cost-of-illness analysis of the economic burden of obsessive-compulsive disorder ...
Oct 12, 2023
0
1
With high-risk drinking on the rise across the nation, experts project the annual cost of treating alcohol-associated liver disease, or ALD, will more than double over the next two decades, increasing from $31 billion in ...
Sep 25, 2023
0
2
Thousands of people could be spared from a hip fracture each year if a new method to identify the risk of osteoporotic fractures were to be introduced in health care. This is the view of the researchers at Lund University ...
Sep 13, 2023
0
1
In their comprehensive meta-analysis (comprising 221 randomized controlled trials involving 65,601 patients), researchers investigated the effectiveness of various pharmacological therapies for acne vulgaris across diverse ...
Jul 25, 2023
0
0
Conduct and emotional problems in adolescents today could cost the NHS nearly £630,000 in annual cost of GP visits alone in adulthood, says new research published in the journal Social Psychiatry and Psychiatric Epidemiology.
Jun 29, 2023
0
0
The Alzheimer's Association is stepping up public pressure on the Biden administration, hoping to convince the government to pay for a new class of promising but expensive Alzheimer's drugs.
May 18, 2023
0
13
President Joe Biden's 2024 proposed budget includes plans to shore up the finances of Medicare, the federal health insurance program that covers Americans who are 65 and up and some younger people with disabilities.
Mar 17, 2023
1
3
The US Food and Drug Administration's approval process for a controversial drug used to treat Alzheimer's was "rife with irregularities," a congressional report said Thursday.
Dec 29, 2022
0
20
Globally, it is widely acknowledged that obesity-related conditions and their complications add hugely to health care costs and productivity losses. In turn this adds a large burden on individuals, their families and on governments.
Sep 14, 2022
0
20
(HealthDay)—Following a months-long and unprecedented review, Medicare officials expect to announce within the next couple of weeks whether the program will cover the controversial Alzheimer's drug Aduhelm. The drug's ...
Jan 7, 2022
0
2
